Muscle stem cell study ends early — but may pave way for future treatments
NCT ID NCT06077734
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether muscle stem cells (mesoangioblasts) from people with muscle loss due to cancer or aging are healthy enough to be used for future cell therapy. Researchers took small muscle samples and blood from 7 participants and measured how well the cells grew and formed muscle. The study was stopped early, so results are limited, but it helps understand if a person's own stem cells could one day treat muscle wasting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATROPHY, MUSCLE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maastricht Universitair Medisch Centrum
Maastricht, Limburg, 6229HX, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- Can nerve changes explain Age-Related muscle loss?
- Muscle loss in aging: can diet and exercise turn back the clock?
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?
- Muscle-Saving supplement may shield seniors from Weight-Loss drug side effect
- Can surgery for stomach or esophageal cancer cloud the mind?